Weycker, D., Chandler, D., Barron, R., Xu, H., Wu, H., Girardi, V., … Lyman, G. H. (2013). Risk of Infection Among Patients with Non-Metastatic Solid Tumors or Non-Hodgkin’s Lymphoma Receiving Myelosuppressive Chemotherapy and Antimicrobial Prophylaxis in US Clinical Practice. In Blood (Vol. 122, pp. 1730–1730). American Society of Hematology. https://doi.org/10.1182/blood.v122.21.1730.1730

Weycker, Derek, David Chandler, Rich Barron, Hairong Xu, Hongsheng Wu, Vincent Girardi, John Edelsberg, and Gary H. Lyman. “Risk of Infection Among Patients with Non-Metastatic Solid Tumors or Non-Hodgkin’s Lymphoma Receiving Myelosuppressive Chemotherapy and Antimicrobial Prophylaxis in US Clinical Practice.” In Blood, 122:1730–1730. American Society of Hematology, 2013. https://doi.org/10.1182/blood.v122.21.1730.1730.

Weycker D, Chandler D, Barron R, Xu H, Wu H, Girardi V, et al. Risk of Infection Among Patients with Non-Metastatic Solid Tumors or Non-Hodgkin’s Lymphoma Receiving Myelosuppressive Chemotherapy and Antimicrobial Prophylaxis in US Clinical Practice. In: Blood. American Society of Hematology; 2013. p. 1730–1730.

Weycker, Derek, et al. “Risk of Infection Among Patients with Non-Metastatic Solid Tumors or Non-Hodgkin’s Lymphoma Receiving Myelosuppressive Chemotherapy and Antimicrobial Prophylaxis in US Clinical Practice.” Blood, vol. 122, no. 21, American Society of Hematology, 2013, pp. 1730–1730. Crossref, doi:10.1182/blood.v122.21.1730.1730.

Weycker D, Chandler D, Barron R, Xu H, Wu H, Girardi V, Edelsberg J, Lyman GH. Risk of Infection Among Patients with Non-Metastatic Solid Tumors or Non-Hodgkin’s Lymphoma Receiving Myelosuppressive Chemotherapy and Antimicrobial Prophylaxis in US Clinical Practice. Blood. American Society of Hematology; 2013. p. 1730–1730.